SF Healthcare Week: Astellas Pharma CEO Naoki Okamura describes the type of assets the company looks for externally, and covers key internal pipeline assets
Jan 15, 2026
09:21
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
He talks about KRAS degraders, claudin 18.2, AAV gene therapy, and more. Plus, how Astellas thinks about the coming patent expiry of Xtandi.